Logo image of INS

INTELLIGENT SYSTEMS CORP (INS) Stock Fundamental Analysis

NYSE:INS - New York Stock Exchange, Inc. - Common Stock

40.15  -0.13 (-0.32%)

Fundamental Rating

4

Taking everything into account, INS scores 4 out of 10 in our fundamental rating. INS was compared to 284 industry peers in the Software industry. INS has a great financial health rating, but its profitability evaluates not so good. INS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

INS had positive earnings in the past year.
INS Yearly Net Income VS EBIT VS OCF VS FCFINS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 5M 10M 15M 20M

1.2 Ratios

Industry RankSector Rank
ROA 15.65%
ROE 20.4%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
INS Yearly ROA, ROE, ROICINS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 20 40 60

1.3 Margins

Industry RankSector Rank
OM 25.35%
PM (TTM) 18.96%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INS Yearly Profit, Operating, Gross MarginsINS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 100 200 300

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, INS has less shares outstanding
INS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INS Yearly Shares OutstandingINS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2M 4M 6M 8M
INS Yearly Total Debt VS Total AssetsINS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M 50M

2.2 Solvency

INS has an Altman-Z score of 19.57. This indicates that INS is financially healthy and has little risk of bankruptcy at the moment.
INS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.57
ROIC/WACCN/A
WACCN/A
INS Yearly LT Debt VS Equity VS FCFINS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 3.99 indicates that INS has no problem at all paying its short term obligations.
A Quick Ratio of 3.99 indicates that INS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.99
Quick Ratio 3.99
INS Yearly Current Assets VS Current LiabilitesINS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for INS have decreased strongly by -10.19% in the last year.
Measured over the past years, INS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.05% on average per year.
Looking at the last year, INS shows a very strong growth in Revenue. The Revenue has grown by 22.63%.
INS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.63% yearly.
EPS 1Y (TTM)-10.19%
EPS 3Y178.06%
EPS 5Y-15.05%
EPS Q2Q%-6.45%
Revenue 1Y (TTM)22.63%
Revenue growth 3Y57.52%
Revenue growth 5Y49.63%
Sales Q2Q%25.53%

3.2 Future

The Earnings Per Share is expected to grow by 40.74% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.85% on average over the next years. This is quite good.
EPS Next Y10.99%
EPS Next 2Y43.49%
EPS Next 3Y34.35%
EPS Next 5Y40.74%
Revenue Next Year28.45%
Revenue Next 2Y25.56%
Revenue Next 3Y20.55%
Revenue Next 5Y18.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
INS Yearly Revenue VS EstimatesINS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
INS Yearly EPS VS EstimatesINS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.39, the valuation of INS can be described as expensive.
The average S&P500 Price/Earnings ratio is at 25.25. INS is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 21.43, INS is valued on the expensive side.
INS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 41.39
Fwd PE 21.43
INS Price Earnings VS Forward Price EarningsINS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.43
INS Per share dataINS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates INS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as INS's earnings are expected to grow with 34.35% in the coming years.
PEG (NY)3.77
PEG (5Y)N/A
EPS Next 2Y43.49%
EPS Next 3Y34.35%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLIGENT SYSTEMS CORP

NYSE:INS (12/28/2021, 8:47:17 PM)

40.15

-0.13 (-0.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)02-10 2022-02-10
Inst Owners29.31%
Inst Owner Change-1.7%
Ins Owners1.24%
Ins Owner Change0%
Market Cap351.10M
Analysts86.67
Price Target60.69 (51.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 41.39
Fwd PE 21.43
P/S 7.83
P/FCF N/A
P/OCF N/A
P/B 8.43
P/tB N/A
EV/EBITDA 22.43
EPS(TTM)0.97
EY2.42%
EPS(NY)1.87
Fwd EY4.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.13
BVpS4.76
TBVpSN/A
PEG (NY)3.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.65%
ROE 20.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 25.35%
PM (TTM) 18.96%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.99
Quick Ratio 3.99
Altman-Z 19.57
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.19%
EPS 3Y178.06%
EPS 5Y-15.05%
EPS Q2Q%-6.45%
EPS Next Y10.99%
EPS Next 2Y43.49%
EPS Next 3Y34.35%
EPS Next 5Y40.74%
Revenue 1Y (TTM)22.63%
Revenue growth 3Y57.52%
Revenue growth 5Y49.63%
Sales Q2Q%25.53%
Revenue Next Year28.45%
Revenue Next 2Y25.56%
Revenue Next 3Y20.55%
Revenue Next 5Y18.85%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A